Coeptis Therapeutics (COEP)

• Market cap: $102M
• 1 day: 1.17%
• 5 days: 14.21%
• 1 month: 57.69%
• 3 months: 17.73%
• 6 months: 9.33%
• Year to date: 12.02%
• 1 year: 31.52%
• 5 years: -91.74%
• 10 years: -91.72%
• Sector: Healthcare
• Industry: Biotechnology

About: Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.

Employees: 6